Dementia Clinical Trials

Clinical trials play a pivotal role in advancing our understanding and treatment of Alzheimer’s Disease and dementia. These trials focus on testing new medications, therapies, and interventions aimed at improving symptoms, slowing disease progression, or preventing onset. They involve diverse participant recruitment to ensure findings are applicable across different groups. Researchers rigorously evaluate safety, efficacy, and potential side effects of experimental treatments. Participation not only offers access to cutting-edge care but also contributes to scientific knowledge crucial for future advancements. By testing new approaches, these trials are instrumental in the ongoing pursuit of effective treatments and, ultimately, a cure for Alzheimer’s Disease and various types of dementia.

Committee Members
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Jacqueline Tuppen

Jacqueline Tuppen

Cogs Club, United Kingdom
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Yong Xiao Wang

Yong Xiao Wang

Albany Medical College, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Kaoru Sakatani

Kaoru Sakatani

The University of Tokyo, Japan
Dementia 2023 Speakers
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Suren A Tatulian

Suren A Tatulian

University of Central Florida, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Constantina Mizis

Constantina Mizis

The Latino Alzheimer’s and Memory Disorders Alliance, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Paul Y Song

Paul Y Song

NKGen Biotech, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Marco Ruggiero

Marco Ruggiero

Silver Spring Sagl, Switzerland
Tags
Facebook
Watsapp